MARKET
IPO

RGNA

RegenLab USA, Inc.
RGNA
NASDAQ
Upcoming IPOs
Expected Listing Date: 2026-12-04
P/E
P/S
P/B
MARKET CAP
INDUSTRY
-0.04~-0.03
-
-
134.77M~179.70M
-
2026-09-25
Public Filing
View Prospectus
2026-10-29
Offering
Price Range: 6.00~8.00
Shares to be Issued: 2500.00K
2026-12-03
Offering End Date
Offering Price: Pending
Post IPO Outstanding: 22.46M
2026-12-04
Listed
No Data
About RGNA
RegenLab is a vertically integrated regenerative medicine company developing and commercializing autologous biologic and tissue-engineering technologies across Musculoskeletal Regeneration, Advanced Wound Care, Medical Aesthetics / Dermatology, and Women’s Health / Urogynecology.

Webull offers RegenLab USA, Inc. stock information, including NASDAQ: RGNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RGNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RGNA stock methods without spending real money on the virtual paper trading platform.